Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q83993745 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000136.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q83993745 | ||
| 024 | ‡a 0000-0001-8233-9638 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q83993745 | ||
| 100 | 0 | ‡a María José Casanova ‡c researcher ‡9 en | |
| 400 | 0 | ‡a M J Casanova ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease | ||
| 670 | ‡a Author's Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment. | ||
| 670 | ‡a Author's Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group. | ||
| 670 | ‡a Author's Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry | ||
| 670 | ‡a Author's Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. | ||
| 670 | ‡a Author's Liver disease and erythropoietic protoporphyria: a concise review. | ||
| 670 | ‡a Author's Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. | ||
| 670 | ‡a Author's Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease. | ||
| 670 | ‡a Author's Rectal hypersensitivity in patients with quiescent ulcerative colitis | ||
| 670 | ‡a Author's Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease" | ||
| 670 | ‡a Author's Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. | ||
| 670 | ‡a Author's Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease. | ||
| 909 | ‡a (orcid) 0000000182339638 ‡9 1 | ||
| 919 | ‡a severeadalimumabinducedthrombocytopeniainapatientwithcrohnsdisease ‡A Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease. ‡9 1 | ||
| 919 | ‡a adalimumabinducedinterstitialpneumoniainapatientwithcrohnsdisease ‡A Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease ‡9 1 | ||
| 919 | ‡a collagenouscolitisrequirementforhighdosebudesonideasmaintenancetreatment ‡A Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment. ‡9 1 | ||
| 919 | ‡a currentconceptsonmicroscopiccolitisevidencebasedstatementsandrecommendationsofthespanishmicroscopiccolitisgroup ‡A Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group. ‡9 1 | ||
| 919 | ‡a effectivenessandsafetyofthesequentialuseofa2and3antitnfagentinpatientswithinflammatoryboweldiseaseresultsfromtheeneidaregistry ‡A Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry ‡9 1 | ||
| 919 | ‡a evolutionafterantitnfdiscontinuationinpatientswithinflammatoryboweldiseaseamulticenterlongtermfollowupstudy ‡A Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. ‡9 1 | ||
| 919 | ‡a liverdiseaseanderythropoieticprotoporphyriaaconcisereview ‡A Liver disease and erythropoietic protoporphyria: a concise review. ‡9 1 | ||
| 919 | ‡a longtermsafetyofinuteroexposuretoantitnfαdrugsforthetreatmentofinflammatoryboweldiseaseresultsfromthemulticentereuropeanteddystudy ‡A Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. ‡9 1 | ||
| 919 | ‡a prevalenceofmalnutritionandnutritionalcharacteristicsofpatientswithinflammatoryboweldisease ‡A Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease. ‡9 1 | ||
| 919 | ‡a rectalhypersensitivityinpatientswithquiescentulcerativecolitis ‡A Rectal hypersensitivity in patients with quiescent ulcerative colitis ‡9 1 | ||
| 919 | ‡a responsetothelettertotheeditorresponsetoinfliximabafterlossofresponsetoadalimumabincrohnsdisease ‡A Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease" ‡9 1 | ||
| 919 | ‡a safetyofthiopurinesandantitnfαdrugsduringpregnancyinpatientswithinflammatoryboweldisease ‡A Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. ‡9 1 | ||
| 996 | ‡2 NKC|uk20181003818 | ||
| 996 | ‡2 SUDOC|14995574X | ||
| 996 | ‡2 RERO|A003081258 | ||
| 996 | ‡2 RERO|A003081257 | ||
| 996 | ‡2 RERO|A003081254 | ||
| 996 | ‡2 RERO|A003081253 | ||
| 996 | ‡2 DNB|1116107376 | ||
| 996 | ‡2 NTA|124842178 | ||
| 996 | ‡2 ISNI|0000000071451221 | ||
| 996 | ‡2 DNB|1052333559 | ||
| 996 | ‡2 SUDOC|185800300 | ||
| 996 | ‡2 JPG|500249872 | ||
| 996 | ‡2 SUDOC|035654147 | ||
| 996 | ‡2 BNC|981058511256406706 | ||
| 996 | ‡2 PTBNP|1781961 | ||
| 996 | ‡2 LC|n 90617354 | ||
| 996 | ‡2 DNB|1074952774 | ||
| 996 | ‡2 BIBSYS|8068594 | ||
| 996 | ‡2 BNCHL|10000000000000000195635 | ||
| 996 | ‡2 ISNI|0000000116519622 | ||
| 996 | ‡2 PTBNP|1202187 | ||
| 996 | ‡2 LC|no2021107130 | ||
| 996 | ‡2 PTBNP|1181136 | ||
| 996 | ‡2 LC|n 2020001713 | ||
| 996 | ‡2 LC|n 82061246 | ||
| 996 | ‡2 ISNI|0000000000858040 | ||
| 996 | ‡2 PTBNP|130631 | ||
| 996 | ‡2 BNC|981058528279706706 | ||
| 996 | ‡2 LC|no2009163631 | ||
| 996 | ‡2 J9U|987007259447105171 | ||
| 996 | ‡2 BIBSYS|4051932 | ||
| 996 | ‡2 BNF|15043887 | ||
| 996 | ‡2 NTA|092951341 | ||
| 996 | ‡2 DNB|1294240420 | ||
| 996 | ‡2 PLWABN|9810595059405606 | ||
| 996 | ‡2 BNE|XX4581342 | ||
| 996 | ‡2 SUDOC|137107285 | ||
| 996 | ‡2 ISNI|0000000066384458 | ||
| 996 | ‡2 BNF|12141953 | ||
| 996 | ‡2 BNE|XX1276391 | ||
| 996 | ‡2 BNF|13175063 | ||
| 996 | ‡2 BNF|13479315 | ||
| 996 | ‡2 LC|no 98066168 | ||
| 996 | ‡2 BNE|XX1563599 | ||
| 996 | ‡2 DNB|1057362522 | ||
| 996 | ‡2 ISNI|000000004660365X | ||
| 996 | ‡2 ISNI|0000000069424849 | ||
| 996 | ‡2 J9U|987007408570105171 | ||
| 996 | ‡2 LC|n 2011088418 | ||
| 996 | ‡2 BNCHL|10000000000000000254529 | ||
| 996 | ‡2 BNC|981058523560606706 | ||
| 996 | ‡2 LC|n 80028400 | ||
| 996 | ‡2 SUDOC|197769071 | ||
| 996 | ‡2 BAV|495_75378 | ||
| 996 | ‡2 BAV|495_87758 | ||
| 996 | ‡2 SUDOC|121246426 | ||
| 996 | ‡2 BNE|XX965090 | ||
| 996 | ‡2 SUDOC|113367643 | ||
| 996 | ‡2 ISNI|0000000059950562 | ||
| 996 | ‡2 DNB|1126532010 | ||
| 996 | ‡2 BAV|495_57847 | ||
| 996 | ‡2 LC|no2010020551 | ||
| 996 | ‡2 DNB|1057092037 | ||
| 996 | ‡2 BNCHL|10000000000000000269920 | ||
| 996 | ‡2 LC|n 2024001339 | ||
| 996 | ‡2 BNCHL|10000000000000000151615 | ||
| 996 | ‡2 LIH|LNB:C0QJ;=_w_3 | ||
| 996 | ‡2 NUKAT|nx2022892859 | ||
| 996 | ‡2 BIBSYS|98055062 | ||
| 996 | ‡2 J9U|987007349785605171 | ||
| 996 | ‡2 RERO|A013376628 | ||
| 996 | ‡2 BNE|XX873196 | ||
| 996 | ‡2 BNE|XX1797101 | ||
| 996 | ‡2 PTBNP|911508 | ||
| 996 | ‡2 DNB|1108329454 | ||
| 996 | ‡2 ISNI|0000000061282786 | ||
| 996 | ‡2 BNF|16129399 | ||
| 996 | ‡2 BNC|981058517323806706 | ||
| 996 | ‡2 BNCHL|10000000000000000156234 | ||
| 996 | ‡2 SUDOC|178287385 | ||
| 996 | ‡2 SUDOC|23594839X | ||
| 996 | ‡2 SUDOC|265440505 | ||
| 996 | ‡2 LC|nb2009017147 | ||
| 996 | ‡2 J9U|987007259447005171 | ||
| 996 | ‡2 DE633|pe41008715 | ||
| 996 | ‡2 BNCHL|10000000000000000086451 | ||
| 996 | ‡2 BNF|15709939 | ||
| 996 | ‡2 ISNI|0000000068080239 | ||
| 996 | ‡2 BNCHL|10000000000000000096131 | ||
| 996 | ‡2 ISNI|0000000032564119 | ||
| 996 | ‡2 RERO|A012002645 | ||
| 996 | ‡2 ISNI|0000000441119374 | ||
| 996 | ‡2 LC|n 2003104991 | ||
| 996 | ‡2 ISNI|0000000060973649 | ||
| 996 | ‡2 ISNI|0000000066397072 | ||
| 996 | ‡2 NDL|00528160 | ||
| 996 | ‡2 ARBABN|000057989 | ||
| 996 | ‡2 LC|ns2023002839 | ||
| 996 | ‡2 BNC|981058516232406706 | ||
| 996 | ‡2 DNB|1057436321 | ||
| 996 | ‡2 SUDOC|035299541 | ||
| 996 | ‡2 ISNI|0000000093757889 | ||
| 996 | ‡2 BAV|495_57846 | ||
| 996 | ‡2 SUDOC|057759634 | ||
| 996 | ‡2 SUDOC|029889375 | ||
| 996 | ‡2 BNCHL|10000000000000000011156 | ||
| 996 | ‡2 BNF|16507112 | ||
| 996 | ‡2 ARBABN|000053562 | ||
| 996 | ‡2 ISNI|0000000005237120 | ||
| 996 | ‡2 SUDOC|226594939 | ||
| 996 | ‡2 CAOONL|ncf11395544 | ||
| 996 | ‡2 LC|n 96028912 | ||
| 996 | ‡2 ISNI|000000006007255X | ||
| 996 | ‡2 BNE|XX839905 | ||
| 996 | ‡2 BNC|981060931236206706 | ||
| 996 | ‡2 ISNI|0000000060000708 | ||
| 996 | ‡2 NTA|146831810 | ||
| 996 | ‡2 CAOONL|ncf10812906 | ||
| 996 | ‡2 BNCHL|10000000000000000024553 | ||
| 996 | ‡2 ISNI|0000000119461366 | ||
| 996 | ‡2 DNB|1057343293 | ||
| 996 | ‡2 PTBNP|1530588 | ||
| 996 | ‡2 SUDOC|162412924 | ||
| 996 | ‡2 ISNI|0000000060674294 | ||
| 996 | ‡2 BNE|XX835398 | ||
| 996 | ‡2 SUDOC|265289203 | ||
| 996 | ‡2 PTBNP|53215 | ||
| 996 | ‡2 DNB|1053146299 | ||
| 996 | ‡2 RERO|A026870661 | ||
| 996 | ‡2 SUDOC|176577017 | ||
| 996 | ‡2 DNB|1057531618 | ||
| 996 | ‡2 BAV|495_367131 | ||
| 996 | ‡2 BNE|XX923847 | ||
| 996 | ‡2 DNB|1258158817 | ||
| 996 | ‡2 BNE|XX1318280 | ||
| 996 | ‡2 SUDOC|080535224 | ||
| 996 | ‡2 NTA|06823564X | ||
| 996 | ‡2 BNF|13498966 | ||
| 996 | ‡2 BNE|XX1399104 | ||
| 996 | ‡2 ISNI|0000000063924121 | ||
| 996 | ‡2 CAOONL|ncf12029690 | ||
| 996 | ‡2 DNB|1157239145 | ||
| 996 | ‡2 SUDOC|155932268 | ||
| 996 | ‡2 BNE|XX1066629 | ||
| 996 | ‡2 ISNI|0000000070230582 | ||
| 996 | ‡2 SUDOC|035221526 | ||
| 996 | ‡2 B2Q|0000117348 | ||
| 996 | ‡2 BNE|XX843705 | ||
| 996 | ‡2 BNF|16975245 | ||
| 996 | ‡2 PTBNP|1896488 | ||
| 996 | ‡2 DNB|1304718530 | ||
| 996 | ‡2 LIH|LNB:CBA_b_;=0L | ||
| 996 | ‡2 ICCU|CUBV047609 | ||
| 996 | ‡2 LC|n 2001038048 | ||
| 996 | ‡2 ISNI|0000000070703896 | ||
| 996 | ‡2 BNF|15526799 | ||
| 996 | ‡2 LC|no 97032962 | ||
| 996 | ‡2 PTBNP|1844843 | ||
| 996 | ‡2 ISNI|0000000061011257 | ||
| 996 | ‡2 NYNYRILM|342259 | ||
| 996 | ‡2 BNCHL|10000000000000000272717 | ||
| 996 | ‡2 LC|nr 95019817 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
